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Abstract
Previous national nutrition surveys in Irish adults did not include blood samples; thus, representative serum 25-hydroxyvitamin D (25(OH)D)
data are lacking. In the present study, we characterised serum 25(OH)D concentrations in Irish adults from the recent National Adult Nutrition
Survey, and determined the impact of vitamin D supplement use and season on serum 25(OH)D concentrations. Of the total representative
sample (n 1500, aged 18þ years), blood samples were available for 1132 adults. Serum 25(OH)D was measured via immunoassay. Vitamin D-
containing supplement use was assessed by questionnaire and food diary. Concentrations of serum 25(OH)D were compared by season and
in supplement users and non-users. Year-round prevalence rates for serum 25(OH)D concentration ,30, ,40, ,50 and ,75 nmol/l were
6·7, 21·9, 40·1 and 75·6 %, respectively (11·1, 31·1, 55·0 and 84·0 % in winter, respectively). Supplement users had significantly higher serum
25(OH)D concentrations compared to non-users. However, 7·5 % of users had winter serum 25(OH)D ,30 nmol/l. Only 1·3 % had serum
25(OH)D concentrations .125 nmol/l. These first nationally representative serum 25(OH)D data for Irish adults show that while only
6·7 % had serum 25(OH)D ,30 nmol/l (vitamin D deficiency) throughout the year, 40·1 % had levels considered by the Institute of Medicine
as being inadequate for bone health. These prevalence estimates were much higher during winter time. While vitamin D supplement use has
benefits in terms of vitamin D status, at present rates of usage (17·5 % of Irish adults), it will have only very limited impact at a population
level. Food-based strategies, including fortified foods, need to be explored.
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Vitamin D, through its active form (1,25-dihydroxyvitamin D),
is essential for intestinal Ca absorption and plays a central role
in maintaining Ca homoeostasis and skeletal integrity(1). There
is a consensus that serum 25-hydroxyvitamin D (25(OH)D)
should be used to assess vitamin D status, as it reflects com-
bined dietary supply and dermal production upon exposure
to UV blue (UVB) sunlight(2). Notwithstanding the importance
of on-going discussions with respect to thresholds for serum
25(OH)D that represent adequacy/insufficiency, there is
widespread acknowledgement of the presence of vitamin D
deficiency in the community and the pressing need to address
this deficiency(3).
Taking indicators of bone health, including rickets and osteo-
malacia, bone mineral density and Ca absorption, for which
there was sufficient evidence to provide a reasonable and
supportable basis for dietary reference intake (DRI) develop-
ment, the North American Institute of Medicine (IOM)’s DRI
committee for Ca and vitamin D proposed a serum 25(OH)D
concentration of 40 nmol/l as the median value above which
approximately half the population might meet its vitamin D
requirement (and below which half might not) and 50 nmol/l
as its estimate of the serum 25(OH)D concentration that would
meet the requirement of nearly all (i.e. 97·5 %) normal healthy
persons(4). These serum 25(OH)D concentrations were used
to specify estimated average requirement (EAR) values for vita-
min D intakes of 400 IU/d (10·0 mg/d) in all age and sex sub-
groups in thepopulation for more than1year, assumingminimal
UVB sunlight exposure, and from which RDA values were
derived for application to individuals (600 and 800 IU/d (15·0
and 20·0 mg/d) of vitamin D for those aged 1–70 and 70þ
*Corresponding author: Professor K. D. Cashman, fax þ353 21 4270244, email k.cashman@ucc.ie
Abbreviations: 25(OH)D, 25-hydroxyvitamin D; DEQAS, Vitamin D External Quality Assessment Scheme; DRI, dietary reference intake; EAR, estimated
average requirements; IOM, Institute of Medicine; NANS, National Adult Nutrition Survey; NHANES, National Health and Nutritional Examination
Survey; UVB, UV blue.
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years, respectively). Furthermore, the DRI committee suggested
that persons are at risk of deficiency when serum 25(OH)D
concentrations are ,30 nmol/l and that there may be some
reason for concern at serum concentrations .125 nmol/l(4).
While the National Health and Nutritional Examination
Survey (NHANES) in the USA(5) and the Canadian Health
Measures Survey(6) have provided useful descriptions of vita-
min D status in North America, equivalent data for the Euro-
pean Union are of variable quality, making it difficult to
estimate the prevalence of vitamin D deficiency across
member states. Knowledge of the distributions of serum
25(OH)D concentrations and vitamin D intakes (and their con-
tributory food sources) in the nationally representative popu-
lations is critical for the quantification of vitamin D deficiency
in the European Union population as well as for devising
food-based strategies for its prevention(3). The importance of
vitamin D nutritional status and the need to monitor it
within populations was highlighted well over a decade ago
by the European Commission in its Report on Osteoporosis
in the European Community: Action for Prevention(7).
As Ireland resides at the latitude band of 51–558N, there are
about 5 months during which UVB-induced dermal synthesis
of vitamin D will not occur(8,9). While there have been
two previous representative surveys of food consumption
at the individual level in Irish adults (in 1990(10) and
1997–1999(11)), and thus estimates for habitual intake of
vitamin D exist, only the recent National Adult Nutrition
Survey (NANS) included blood samples for the analysis of
nutritional status as well as collection of data on food and
supplement consumption and nutrient intakes(12). To date,
data on serum 25(OH)D concentrations in healthy Irish
adults have come from relatively small cross-sectional as
well as intervention studies(13–21).
Following a key recommendation in the 1998 European
Commission Osteoporosis Report(7) in relation to Ca and
vitamin D education of the general public and health pro-
fessionals, there has been some progress on such awareness
campaigns in Ireland(22). Whiting et al.(6) recently showed that
vitamin D supplement use in Canadians was associated with
higher serum 25(OH)D concentrations as well as an attenuated
effect of season on vitamin D status. Therefore, the aims of the
present study were first, to characterise serum 25(OH)D con-
centration in the NANS participants, and second, to explore
the impact of vitamin D supplement use on achieving serum
25(OH)D above cut-offs proposed by the DRI committee in
these adults stratified by age, sex and season of sampling.
Subjects and methods
Subject sampling and recruitment procedures and methods
of data collection
A detailed description of the methodology used in the NANS
has been reported elsewhere(12). However, a concise overview
of salient aspects of subject sampling and recruitment pro-
cedures, as well as methods of data collection and laboratory
analysis pertinent to the objectives of the present work, are
outlined later.
Ethics approval
The study was approved by the Clinical Research Ethics
Committee of the Cork Teaching Hospitals, University
College Cork and the Human Ethics Research Committee of
University College Dublin.
Sampling procedure, inclusion/exclusion criteria and
sample recruitment
The fieldwork phase of the NANS was carried out between
October 2008 and April 2010, providing a seasonal balance
to the data and biological sample collection. To achieve a
nationally representative sample of community-dwelling
adults aged 18 years and over, a quota sampling approach
was adopted using data from the most recently published
census(23). Criteria used to achieve the quota sample were
sex (50:50) within each age group (18–35 years (35 %),
36–50 years (29 %), 51–64 years (21 %) and $65 years
(15 %)). As the Republic of Ireland does not have a national
identification system for adults, a database of names and
addresses held by Data Ireland (National Postal Service) was
used to randomly select persons in twenty geographical
clusters across the country, selected to provide proportional
representation across the urban–rural continuum by dis-
tinguishing cities from towns, villages and open countryside.
A sample of 1500 free-living adults to represent a popu-
lation of 4·239 million people participated in the dietary
survey. The sample size was chosen to deliver at least 100
individuals in the least populated age and sex sub-groups.
There were few exclusion criteria, other than pregnancy/lacta-
tion and inability to complete the survey due to disability, as
described previously(24). An introductory letter plus an infor-
mation leaflet were posted to each person selected from the
database. Shortly after this mail contact, a researcher called
to each potential respondent’s home to introduce the survey
and invite participation. If the person agreed to participate,
a consent form was signed and the study protocol com-
menced. If the person was not at home, the researcher
called on three more occasions on different days and at differ-
ent times, before excluding them as non-contactable. If the
person declined to participate in the survey, the researcher
attempted to obtain information such as age, education and
occupation, in order to describe non-respondents. All eligible
and willing participants gave their written consent according
to the Helsinki declaration.
The final response rate for the survey was 59·6 %. Analysis
of the demographic features in this sample has shown it to
be a representative sample of Irish adults with respect to
age, sex, social class and geographical location when com-
pared to census data(23). Participation in the survey did not
require provision of a blood sample. Of those that completed
the 4 d food diary, 75·5 % of respondents (n 1132) provided a
blood sample (of which 79 % were fasting). The following
were the reasons why about one-quarter of the entire
sample did not supply a blood sample: time constraints,
lack of interest in this aspect, fear of needles, unsuccessful
attempt or illness. The demographic features of the group of
Vitamin D status of a representative sample of Irish adults 1249
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participants who provided a blood sample and those in the
entire sample are shown in Table S1 (available online).
Food intake data collection, food quantification and
estimation of nutrient intake
A 4 d food diary was used to collect food and beverage intake
data, as described in detail elsewhere(12). A quantification pro-
tocol that had been established by the Irish Universities Nutri-
tion Alliance for the North/South Ireland Food Consumption
Survey (in 1997–99(11)), and described in detail elsewhere(25),
was updated for the NANS. Food intake data were analysed
using WISPq (Tinuviel Software), which uses data from
McCance and Widdowson’s The Composition of Foods, sixth
and fifth editions plus all nine supplemental volumes to gen-
erate nutrient intake data, as described elsewhere(12,26). Modi-
fications were made to the food composition database to
include recipes of composite dishes, nutritional supplements,
generic Irish foods that were commonly consumed and
new-foods on the market, including vitamin D-fortified
foods(27).
Participant questionnaires and anthropometry
All participants completed questionnaires which collected
information on the respondent’s socio-demographics, edu-
cation levels, attitudes to their own diet and weight and sup-
plement usage, as described in detail elsewhere(12).
Information on social class and education level, smoking
status, alcohol intake and medication usage (including those
which contained nutrients) was also collected. Seasonality
was based on the date the respondents provided the blood
sample – November to March (representing the ‘winter’
period) or April to October (representing the ‘summer’
period) – consistent with studies based on NHANES(5) and
the recent analysis of Canadian Health Measures Survey for
vitamin D status(6). Anthropometric measures including
height, weight, waist and hip circumference and measures of
body composition were taken in the respondent’s homes, as
described previously(12).
Assessment of vitamin D-containing supplement
consumption
Present supplement use was assessed by the respondents’
answer to the question ‘Do you take any vitamin, mineral or
food supplements?’, which was included in the self-adminis-
tered health and lifestyle questionnaire. Respondents also
entered each supplement, as it was consumed, into the 4 d
food diary. Researchers checked that respondents who had
reported using supplements in the questionnaire, which was
administered at the start of the recording period, entered the
supplements into the food diary when they were consumed.
Information on product brand name, nutrient composition,
as well as daily dose and frequency of consumption was
obtained for each supplement taken. Researchers entered
supplements into the food consumption database in the same
way as they entered foods from the 4 d diaries. In this way,
supplement consumption was measured alongside food
consumption. By accounting for contribution of vitamin D
from supplemental forms, the vitamin D intake data from all
sources (food and supplements) as well as from food sources
only were generated.
Blood collection and analysis of serum
25-hydroxyvitamin D
Blood samples were collected by venepuncture into a vacutai-
ner tube by a qualified nurse at designated centres within the
survey area or in the respondent’s home if the respondent
could not travel. Blood samples were transported to the labora-
tory for further processing and serum was stored at2808C until
required for analysis. The 25(OH)D concentrations were
measured at University College Cork in all serum samples
using an ELISA (OCTEIAw 25-Hydroxy Vitamin D, Immuno
Diagnostic Systems Limited). The intra- and inter-assay CV for
the ELISA method was 5·9 and 6·6 %, respectively. This ELISA
assay is used for the quantitative determination of serum/
plasma 25(OH)D; further details have been described pre-
viously(28). The quality and accuracy of serum 25(OH)D anal-
ysis in our laboratory are assured on an ongoing basis by
participation in the Vitamin D External Quality Assessment
Scheme (DEQAS, Charing Cross Hospital, London, UK). A com-
parison of the performance of the present ELISA assay with that
of liquid chromatography–MS in relation to DEQAS (n 20)
samples for 2008 shows a high correlation (ELISA ¼ 1·0258 £
liquid chromatography–MS ¼ 3·0351; r 0·96). Measured serum
25(OH)D concentrations were compared with cut-offs for
25(OH)D as per the IOM DRI committee’s recent definitions:
persons are at risk of deficiency at serum 25(OH)D concen-
trations below 30 nmol/l, and 40 and 50 nmol/l are consistent
with the EAR-like and RDA-like serum values, respectively(4).
In addition, serum 25(OH)D concentrations .125 nmol/l
have been suggested by the IOM DRI committee as being
possibly some reason for concern(4). As the Task Force for
the Clinical Guidelines Subcommittee of The Endocrine
Society have recently suggested that to maximise the effect
of vitamin D on Ca, bone and muscle metabolism, serum
25(OH)D concentration should exceed 75 nmol/l(29), we also
used this cut-off for comparison purposes.
Comparison of the mathematically modelled seasonal
variation in serum 25-hydroxyvitamin D due to sun
exposure with observed data from the National Adult
Nutrition Survey
Diffey(30) recently published a mathematical model which pre-
dicts the changes in serum 25(OH)D concentration arising
from exposure to UVB sunlight over the course of twelve
calendar months. The model uses estimates and data on
response of serum 25(OH)D following a specified exposure
to UVB sunshine (accounting for synthesis and decay rates
for serum 25(OH)D) and incorporates UK data on daylight
hours, annual standard erythema dose (standardised measure
of erythemogenic UV radiation (representative of the South of
England)), as well as hours spent outside per d. We used
K. D. Cashman et al.1250
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Diffey’s model, but substituted Irish data for mean hours of
sunlight in Ireland. We also made two broad assumptions in
using Diffey’s model and some of his estimates: as most of
the Republic of Ireland (coverage area for the NANS) resides
between approximately 51 and 548N, we used the UK stan-
dard erythema dose data which was representative for the
South of England (as standard erythema dose data is not avail-
able for Ireland), and as the NANS survey did not assess the
average time spent outdoors, we used the estimates from
the UK adult data of Hyppo¨nen & Power(31), as per Diffey(30).
Data manipulation and statistical analysis
Data manipulation was conducted using SPSSq version 15.0
for Windowse (SPSS, Inc.). The x 2 analyses were performed
to compare demographic data for the entire NANS sample
(n 1500) and those NANS participants who provided a blood
sample (n 1132). Descriptive statistics (frequencies, means)
were used to estimate serum 25(OH)D concentrations by
threshold, supplement use, age group, sex and season of
blood sample collection. All estimates were based on data
weighted to represent the Irish adult population aged 18–84
years(23). Variance estimates (95 % CI) were calculated, and
unpaired t tests were used to test differences between preva-
lence and mean estimates of serum 25(OH)D and mean
daily vitamin D intakes. Statistical significance was defined
as P,0·05.
Results
There was no significant difference in key demographic
characteristics among the entire NANS sample (n 1500) and
the subset of NANS participants who provided a blood
sample (n 1132; see Table S1; available online).
Essentially all (99·5 %) the NANS adults in the present anal-
ysis (n 1132) were self-reported Caucasians, and because
of the extremely small sample size of either self-reported
non-Caucasians (n 3) or those that did not specify their ethni-
city (n 3), these were not treated separately in the analyses.
As fasting v. non-fasting blood sample was not a significant
determinant (P¼0·886) of serum 25(OH)D concentration
after accounting for age, sex and month of sampling, all
serum 25(OH)D data were included in the analyses.
The mean serum 25(OH)D concentration in Irish adults
(n 1132) sampled throughout the year was 60·0 (95 % CI 58·6,
61·4) nmol/l. The 2·5th, 5th, 10th, 25th, 50th, 75th, 90th, 95th
and 97·5th percentile of year-round serum 25(OH)D were
26·0, 28·5, 32·3, 41·5, 57·2, 74·3, 92·0, 102·0 and 111·8 nmol/l,
respectively. The mean serum 25(OH)D concentration in
summer (n 632) and winter (n 500) was 65·5 (95 % CI 63·6,
67·4) nmol/l and 53·1 (95 % CI 51·2, 55·1) nmol/l, respectively
(P,0·0001). The mean daily intake of vitamin D from food
sources only and from all sources (food and supplements) of
the Irish adults (n 1132) was 160 (95 % CI 153, 166) and 219
(95 % CI 201, 237) IU/d (4·0 (95 % CI 3·8, 4·2) and 5·5 (5·0,
5·9) mg/d), and did not differ by season (P¼0·518 and
P¼0·494 for all sources and food sources only, respectively),
accounting for age and sex (data not shown).
The impact of UVB sun exposure on predicted serum
25(OH)D concentrations from March to September (represent-
ing a period when vitamin D status should rise from its nadir
to close to its peak(8,9)) is shown in Fig. 1. The observed mean
monthly serum 25(OH)D concentrations for this period in
those NANS participants not taking a vitamin D-containing
supplement (and thus relying on dietary and dermal sources)
aligned closely with predicted values arising from Diffey’s
mathematical model(30), which assumes a constant input of
vitamin D from non-dermal sources (i.e. diet and possibly
stores). The difference between mean observed serum
25(OH)D concentrations in those sampled in March and
September was 32 nmol/l, and the corresponding average
difference was 36 nmol/l using the predicted values from the
model arising from increased dermal synthesis of vitamin D
on exposure to UVB sunlight from March to September.
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Fig. 1. Modelled variation in serum 25-hydroxyvitamin D (25(OH)D) from March to September for the Republic of Ireland (solid curve) using Diffey’s model(30) and
the mean (SD) monthly measured serum 25(OH)D concentrations (data points with error bars) for adults in the National Adult Nutrition Survey. (A colour version of
this figure can be found online at http://www.journals.cambridge.org/bjn)
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The prevalence rates for serum 25(OH)D concentration
below the IOM DRI committee thresholds, stratified by
season and sex (where sample number allowed for
meaningful comparisons), are shown in Table 1. Year-round
prevalence rates for serum 25(OH)D concentration ,30,
,40 and ,50 nmol/l were 6·7, 21·9 and 40·1 %, respectively
(Table 1). The prevalence of vitamin D deficiency (serum
25(OH)D ,30 nmol/l) was 11·1 % in the total group of
adults in winter, and with no difference between those aged
18–64 years and .65 years (data not shown). This dropped
to 3·4 % in summer. For serum 25(OH)D ,40 nmol/l (the
EAR-like concentration), prevalence estimates more than
doubled from 15·4 % in summer to 31·1 % in winter. For
serum 25(OH)D ,50 nmol/l (the RDA-like concentration),
estimates ranged from 21·5 % (in those aged 51–64 years old
in summer) to 58·7 % (in those aged 36–50 years in winter).
Even in summer, when status would be at its best for
most people, between 21·5 and 35·8 % had serum 25(OH)D
concentrations ,50 nmol/l (Table 1). The prevalence of
serum 25(OH)D ,50 nmol/l in winter was lowest in the
65þ years age category (48·1 %) compared to younger age cat-
egories (54·4–58·7 %), but this trend was reversed in summer
with the highest prevalence in the 65þ years olds (35·8 %;
Table 1). Year-round, winter and summer prevalence rates
for serum 25(OH)D concentration ,75 nmol/l in the entire
cohort of Irish adults (n 1132) were 75·6, 84·0 and 69·0 %,
respectively.
For each of the IOM DRI committee serum 25(OH)D cut-
offs used in the present analysis (,30, ,40 and ,50 nmol/l),
the differences in prevalence estimates between winter and
summer (significant in all cases) were of a much greater
magnitude (1·9–3·2 times higher in winter, for all adults)
compared to differences in prevalence estimates between
sexes within a season (typically less than 20 %, and non-
significant differences in all cases; Table 1).
A total of fifteen persons (eight men and seven women;
1·3 %) had serum 25(OH)D concentrations .125 nmol/l,
a serum threshold which according to the DRI committee
may be some reason for concern(4). Of these, eleven were
sampled in summer and of the four that were sampled in
winter, two were supplement users (667 and 2000 IU/d
(16·7 and 50·0 mg/d), respectively) and one of the two non-
users had been on a sun vacation before sampling.
Of the entire cohort of Irish adults aged 18–84 years, 17·5 %
were taking a vitamin D-containing supplement. Vitamin
D-containing supplement use was higher in women (55·6 %)
than men (44·4 %), and in older (.65 years; 27·6 %) than
younger adults (18–65 years; 16·0 %). The median (min,
max) content of the vitamin D-containing supplements was
200 (10, 2412) IU (5·0 (0·25, 60·3) mg) vitamin D. Among the
supplement users, 67·2 and 15·1 % took #200 IU/d (5·0 mg/d)
and between 200 and #400 IU/d (5·0 and # 10·0mg/d) as
supplemental vitamin D, respectively. Only a small percentage
(3·5 %) of the total population had supplemental intakes of
vitamin D $1000 IU/d (25·0mg/d) and these were mostly
aged .50 years, and mostly female (data not shown).
The association between vitamin D-containing supplement
use and serum 25(OH)D concentration by season was also
examined (Table 2). Seasonal differences in mean serum
25(OH)D concentration were evident in supplement non-
users but not in supplement users. For example, the change
in mean serum 25(OH)D with seasonality (summer less
winter) was 13·9 nmol/l in supplement non-users and
5·1 nmol/l in users. Overall, in both winter and summer, sup-
plement users had higher serum 25(OH)D concentrations
than did non-users. Interestingly, the mean winter serum
25(OH)D concentration in vitamin D-containing supplement
Table 1. Distribution of subjects by serum 25-hydroxyvitamin D (25(OH)D) concentration, season and sex in the National Adult
Nutrition Survey of adults aged 18–84 years in Ireland, 2008–10*†‡
(Number of subjects, percentages and 95 % confidence intervals)
Year round Winter Summer
Serum 25(OH)D concentration n % 95 % CI n % 95 % CI n % 95 % CI
,30 nmol/l
Age 18–84 years 77 6·7 5·2, 8·3 57 11·1 8·6, 13·5 20 3·4 2·1, 4·7
Female 34 6·0 4·5, 7·5 23 10·3 7·8, 12·8 11 3·4 2·1, 4·7
Male 43 7·4 5·8, 9·0 34 11·8 9·3, 14·2 9 3·4 2·0, 4·7
,40 nmol/l
Age 18–84 years 250 21·9 18·2, 25·5 156 31·1 26·7, 35·5 94 15·4 12·3, 18·5
Female 127 22·3 18·3, 26·3 71 32·6 26·6, 37·5 56 16·0 12·6, 19·4
Male 123 21·4 18·1, 24·7 85 29·6 25·7, 33·6 38 14·8 12·1, 17·4
,50 nmol/l
Age 18–84 years 453 40·1 35·3, 44·9 273 55·0 49·2, 60·8 180 28·9 24·7, 33·1
Female 222 39·4 34·2, 44·5 121 55·5 50·2, 60·7 101 29·9 25·3, 34·4
Male 231 40·8 36·4, 45·2 152 54·5 48·1, 61·0 79 28·0 24·2, 31·8
Age 18–35 years 181 42·2 37·7, 46·7 110 54·4 49·1, 59·6 71 31·3 27·1, 35·4
Age 36–50 years 129 38·3 33·1, 43·6 68 58·7 51·3, 66·0 61 27·6 23·4, 31·8
Age 51–64 years 80 35·7 32·4, 39·0 52 55·4 51·4, 59·4 28 21·5 18·8, 24·2
Age 65–84 years 63 44·0 41·5, 46·5 43 48·1 45·1, 51·0 20 35·8 34·1, 37·6
* There was a significant difference between winter and summer for all age and sex categories (P,0·01).
† There were no significant differences between males and females (P.0·1 in all cases; unpaired t test).
‡ Division into age groupings only possible for serum 25(OH)D ,50 nmol/l, as base numbers too low for other two serum 25(OH)D categories.
K. D. Cashman et al.1252
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users (66·1 nmol/l) was similar to that achieved by non-users in
summer (64·3 nmol/l, P.0·1; Table 2). The mean daily intake
of vitamin D from food sources only did not differ between
supplement users and non-users in either season after
accounting for age and sex (P.0·2; data not shown).
Prevalence of serum 25(OH)D concentration below 30, 40
and 50 nmol/l for year-round and winter only, and stratified
by supplement use, are shown in Table 3. In general, the highest
prevalence of low status (less than 30, 40 and 50 nmol/l) was in
non-users in winter, and supplement use was associated with
lower prevalence estimates during winter, irrespective of
which threshold of serum 25(OH)D was used. However, cau-
tion is warranted as the numbers in some of the sub-groups
are quite low.
When the total group of adults was stratified into those with
habitual vitamin D intakes (irrespective of whether from food
alone or food plus supplements) above and below the IOM
dietary EAR for vitamin D (400 IU/d (10·0 mg/d)(4)), the preva-
Table 2. Serum 25-hydroxyvitamin D (25(OH)D) concentration by vitamin D-containing supplement use, season, sex and age group in subjects in the
National Adult Nutrition Survey of adults aged 18–84 years in Ireland, 2008–2010
(Mean values, number of subjects and 95 % confidence intervals)
Winter Summer
Supplement use No supplement use Supplement use No supplement use
n Mean 95 % CI n Mean 95 % CI n Mean 95 % CI n Mean 95 % CI
Age (years)
18–84 88 66·1* 60·7, 71·4 412 50·4 48·4, 52·4 110 71·2* 66·7, 75·7 522 64·3† 62·2, 66·4
18–35 31 65·6* 55·9, 75·3 172 50·8 47·8, 53·8 24 64·0 54·7, 73·3 203 64·3† 61·0, 67·6
36–50 16 62·3* 50·3, 74·3 99 49·7 45·7, 53·7 30 69·7 62·9, 76·5 188 66·8† 63·1, 70·5
51–64 19 66·2* 54·6, 77·8 75 50·7 45·7, 55·6 38 74·1* 68·2, 80·0 92 63·3† 59·0, 67·5
65–84 22 69·2* 57·5, 80·9 66 49·6 44·3, 54·8 18 77·4* 57·9, 96·8 39 54·7‡ 48·3, 61·1
* Mean values were significantly different from no supplement use within same season (P,0·05; unpaired t test).
† Mean values were significantly different from no supplement use in winter (P,0·001; unpaired t test).
‡ Mean values were significantly different from supplement use in winter (P,0·05; unpaired t test); there was no significant difference between summer and winter for
supplement users (P.0·1 in all cases).
Table 3. Distribution of subjects taking a vitamin D-containing supplement, by serum 25-hydroxyvi-
tamin D (25(OH)D) concentrations and sex in subjects in the National Adult Nutrition Survey of
adults aged 18–84 years in Ireland, 2008–10*
(Number of subjects, percentages and 95 % confidence intervals)
Supplement use No supplement use
Serum 25(OH)D concentration n % 95 % CI n % 95 % CI
Year round
, 30 nmol/l
Age 18–84 years 6 3·7† 1·0, 6·3 70 7·6 5·8, 9·4
Female 3 3·8‡§ 1·3, 6·4 30 6·8 5·0, 8·6
Male 3 3·5‡§ 0·7, 6·3 40 8·3 6·5, 10·1
, 40 nmol/l
Age 18–84 years 19 10·1† 5·3, 15·0 229 24·5 21·1, 28·4
Female 11 11·3† 6·1, 16·5 115 25·4 21·3, 29·7
Male 8 8·9† 4·5, 13·4 114 24·0 21·0, 27·1
, 50 nmol/l
Age 18–84 years 46 24·2† 16·6, 32·1 405 43·8 39·1, 48·5
Female 24 23·2† 15·2, 31·2 197 43·9 38·6, 49·2
Male 22 25·4† 18·1, 32·8 208 43·6 39·5, 47·7
Winter only
, 30 nmol/l
Age 18–84 years 5 7·5‡§ 1·8, 13·1 51 12·1 8·6, 15·6
Female 3 11·1‡§ 4·4, 17·8 20 11·0 7·2, 14·7
Male 2 3·9‡§ 0·3, 8·1 31 13·1 9·8, 16·4
, 40 nmol/l
Age 18–84 years 13 15·8† 6·4, 25·3 142 34·2 27·8, 40·6
Female 7 16·3† 5·9, 26·7 65 36·0 28·2, 43·7
Male 6 15·3† 7·0, 23·7 77 32·4 27·3, 37·5
, 50 nmol/l
Age 18–84 years 24 26·8† 14·4, 39·2 248 59·8 51·9, 67·8
Female 11 23·0† 10·0, 35·9 112 61·2 51·9, 70·5
Male 13 30·5† 18·9, 42·1 136 58·4 51·8, 65·8
* There were no significant differences between males and females (P.0·1 in all cases; unpaired t test).
† Significantly different from no supplement use (P,0·05; unpaired t test).
‡ Interpret with caution due to the base number #5.
§ Statistical analysis not performed due to the small sample size.
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lence of serum 25(OH) $40 nmol/l was much higher (81 %)
in those reaching the EAR than in those failing to meet this
target (67 %) in winter.
Discussion
Vitamin D status in populations living at latitudes above 408N
is at its lowest in the winter period, during which the capacity
for UVB sunlight-induced dermal synthesis of vitamin D is
much reduced and even absent(8,9). In the present study, the
prevalence of serum 25(OH)D concentration ,30 nmol/l
(the IOM threshold for vitamin D deficiency(4)) during
winter was 11·1 % compared to 3·4 % during summer. This sea-
sonal difference was also evident in prevalence estimates of
serum 25(OH)D below the IOM DRI committee’s thresholds
of 40 and 50 nmol/l, which relate to covering needs of
vitamin D in half and nearly all (97·5 %) of the general healthy
population, respectively(4). Overall, the year-round prevalence
estimates of serum 25(OH)D ,30 and ,50 nmol/l in Irish
adults (6·7 and 40·1 %, respectively) agree well with those
of the US adults aged .19 years in NHANES 2001–2006
(9·1 and 34·9 %, respectively)(5), but while the later survey
included a multi-ethnic population sample, the NANS was
overwhelmingly Caucasian. Non-whites in NHANES had
three to approximately ten times higher year-round preva-
lence of serum 25(OH)D ,30 nmol/l compared to whites
(at 3 %)(5). Whiting et al.(6) recently showed in the Canadian
Health Measures Survey that the year-round prevalence esti-
mates for serum 25(OH)D concentrations ,30, ,40 and
,50 nmol/l were 3·0, 8·7 and 19·9 %, respectively, in whites
and 16·3, 30·5 and 51·4 %, respectively, in non-whites. Thus,
prevalence estimates for these different degrees of low
vitamin D status in Irish adults were much higher (about
double) than that of North American Caucasians(5,6). Data
from the UK-based National Diet and Nutrition Survey of
adults (18–64 years)(32) show that year-round prevalence esti-
mates of serum 25(OH)D ,30, ,40 and ,50 nmol/l were
23·5, 41·0 and 55·5 %, respectively, while in older adults
(65–84 years)(33), year-round prevalence estimates of serum
25(OH)D ,30 and ,40 (,50 not reported) nmol/l were
15·3 and 31·5 %, respectively. These UK surveys included a
multi-ethnic population sample, but did not report serum
25(OH)D concentrations by ethnicity.
The mean serum 25(OH)D concentrations during winter in
vitamin D-containing supplement users in the present study
were as high as mean concentrations in non-users during
summer, suggesting an ability of vitamin D supplement use
to modulate an average seasonal decline of approximately
12 nmol/l in non-users. However, vitamin D deficiency
(serum 25(OH)D concentrations ,30 nmol/l) still occurred
in 7·5 % of vitamin D-containing supplement users in winter,
and in 12·1 % non-users. While these 6-month extended
winter and summer periods have been used in NHANES(5)
and the Canadian Health Measures Survey(6), and we have
used for comparison purposes, this approach does not
reflect true seasons as defined by the movement of the sun.
In Ireland, winter would finish and spring begin by about
March/April, and consequently, the nadir in serum 25(OH)D
concentration would be at about March and a peak at about
September/October(8,9). This was illustrated in the present
study by an average difference in mean serum 25(OH)D con-
centration of about 32 nmol/l between those sampled in
March and September. Diffey’s mathematical model of seaso-
nal change in serum 25(OH)D(30) showed a steady daily
increase in serum 25(OH)D from March to the end of May,
even greater daily increments during June, July and August
and a possible peak by early September. Sun exposure was
not assessed as part of NANS, but the observed mean monthly
serum 25(OH)D concentrations were in close agreement with
predicted serum 25(OH)D concentrations from the model. It is
assumed within the model that dietary vitamin D intake does
not change by season (an assumption strengthened by the
present vitamin D intake findings), and thus the improvement
in status during the extended summer period arises from
increased dermal synthesis of vitamin D upon exposure to
UVB sunshine. However, the risk of skin damage and cancer
prohibits use of sunshine exposure as a public health measure
to correct endemic low-vitamin D status. In addition, even in
summer time, when status should be its highest, 3·4 % of
NANS participants still had serum 25(OH)D concentrations
,30nmol/l (and 28·9%, ,50nmol/l). While dietary supply of
vitamin D takes on increasing importance, it is low for most
European populations(34). The mean daily intake of vitamin
D for the present group of Irish adults was 209 IU/d (5·2 mg/d).
The present study showed that compared to non-users, vita-
min D-containing supplement use was important in achieving
a higher mean serum 25(OH)D in winter (15·7 nmol/l, on
average), and, albeit to a lesser degree, also in summer
(6·8 nmol/l, on average). We have previously shown that vita-
min D-containing supplement use by Irish post-menopausal
women was associated with a higher serum 25(OH)D concen-
tration in summer (as well as winter) compared to non-
users(19). Whiting et al.(6) also recently reported higher mean
serum 25(OH)D concentrations among supplement users in
both winter and summer.
Of note, while vitamin D-containing supplement use
appeared to dramatically reduce the prevalence of serum
25(OH)D concentrations ,30, ,40 and ,50 nmol/l com-
pared to that in non-users in both the Canadian(6) and Irish
surveys, it did not prevent their occurrence in winter or
even totally in summer. For example, even though taking a
vitamin D-containing supplement, one individual (0·9 %) in
the present survey and seventeen individuals (1·9 %) in the
Canadian survey(6) had serum 25(OH)D concentrations
,30 nmol/l in summer, as compared to a prevalence of
3·6 and 4·7 % in Irish and Canadian non-users, respectively.
Furthermore, despite conferring a benefit in terms of higher
mean serum 25(OH)D concentrations in those adults who
used vitamin D-containing supplements, it is worth re-empha-
sising that only 17·5 % of the Irish adults aged 18–84 years
(16 % of those aged 18–64 years) consumed them. The pre-
vious national Irish nutrition survey in 1997–1999 showed
that 15 % of adults aged 18–64 years consumed a vitamin
D-containing supplement(23). Such data might suggest that
the efforts at increasing public and health professional aware-
ness of vitamin D nutritional status(22) have not translated into
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increased uptake of supplement use. Gahche et al.(35) recently
showed that rates of vitamin D-containing supplement use in
the US adults aged 20–59 years participating in various cycles
of NHANES remained stable from the period 1999–2002 to
2003–2006 (average 35 %), but increased significantly in
women aged 60þ years (49·7–56·3 %, respectively), but not
men. While previous data is not available to compare against,
the rate of vitamin D supplement use (27·6 %) in older Irish
adults (.65 years) in the present survey was much higher
than in younger adults. The higher use of vitamin D-contain-
ing supplements in the 65þ age group compared to younger
age groups may underpin the lower percentage of subjects
with winter serum 25(OH)D less than 50 nmol/l in the
former compared to later groups. However, despite the
higher use of vitamin D-containing supplements in these
older subjects, they had the highest prevalence of serum
25(OH)D less than 50 nmol/l during summer, likely due to a
lower efficiency of dermal production of vitamin D upon
exposure to UVB sunlight compared to younger adults(36,37).
Within the 65þ age group, a high proportion (70 %) of the
vitamin D-containing supplement users also consumed sup-
plemental Ca, which may reflect self- or medically prescribed
supplement use for osteoporosis prevention. Also of note, and
possibly a contributory factor in the better vitamin D status
in North American whites, is the much higher uptake of
vitamin D supplement use (between 32 and 56·3 % depending
on age, sex and country) by individuals in the USA and
Canada(5,6) compared to Ireland.
Although supplements contribute 9 and 17 % to vitamin D
intakes in Irish adults aged 18–64 years and $65 years,
respectively, and almost a quarter of vitamin D intakes in
women and 12 % in men in the UK adult population(38), over-
all mean daily intakes of vitamin D are low, so these contri-
butions, while proportionally high, are quantitatively low.
Furthermore, evidence seems to suggest that the population
intake of vitamin D from supplements in other European
countries is also quite low(34). This is a function mainly of
the relatively low vitamin D content of most supplements in
some countries relative to DRI, particularly the new North
American values(4). For example, the median concentration
of vitamin D in the supplements consumed by participants
in the present survey was only 200 IU/d (5·0 mg/d). Even
within vitamin D-containing supplement users, 53 % failed to
reach the EAR intake target for vitamin D (400 IU/d;
10·0 mg/d). On the other hand, the low content possibly
helped protect against serum 25(OH)D concentration
.125 nmol/l, with only 1·5 % of supplement users exceeding
this threshold in the present survey.
With the exception of specific patient groups, supplemen-
tation as a preventive strategy is likely to have limited effec-
tiveness in population health promotion in Europe due to
relatively low compliance in some populations. It is clear
that sustainable solutions to counteract the prevailing high
prevalence of low vitamin D status will require appropriate
food-based strategies that will prevent vitamin D inadequacy
across all sectors of the population. The present findings
showed how achieving the EAR of 400 IU (10·0 mg) vitamin D/d
protected all but 19% of adults in maintaining winter-time
serum 25(OH) $40 nmol/l (the average requirement for
vitamin D in terms of bone health); however, over 85–97 %
of Irish adults have intakes #400 IU (10·0 mg), depending
on age and sex group. Vitamin D fortification (mandatory or
voluntarily) of food has been viewed by some as an alterna-
tive, feasible and effective measure once applied in an evi-
dence-based approach. At present, vitamin D intake from
voluntary fortified foods in Europe is low(34), highlighting
the need to explore strategies for fortification of select foods
with a content of vitamin D, which will allow individuals to
attain dietary targets.
In conclusion, this is the first nationally representative data
on vitamin D status for Irish adults and it shows that while
serum 25(OH)D concentrations reflective of vitamin D
deficiency only occur in 6·7 % of the population throughout
the year, 40·1 % have levels considered by the IOM as being
inadequate for bone health. These prevalence estimates are
much higher during winter time. While vitamin D supplement
use has benefits in terms of higher mean serum 25(OH)D con-
centrations and lower prevalence rates of low status, at pre-
sent rates of usage (17·5 % of Irish adults), supplement use
will have only very limited impact at a population level.
Thus, there is a need to explore food-based strategies for
improving vitamin D status, including fortified foods.
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